South African Health Products Regulatory Authority (SAHPRA) approves Lipiodol® Ultra-Fluid for visualization, localization and vectorization during transarterial chemo-embolization (TACE) of intermediate-stage hepatocellular carcinoma in adults

Additional information related to 2021 financial outlook

2020 annual results

Gadopiclenol: positive results for Phase III clinical trials

Launch of OptiProtect™ 3S, a new range of technical services for Guerbet injection solutions

2020 revenue

Sarah Dayre joins the Guerbet Executive Committee as Senior Vice President for Technical Operations

2020 Corporate Social Responsibility Gaïa-Index: Guerbet ranks top of “Healthcare” category

Guerbet launches a new multi-patient solution, with no compromise on efficiency and patient safety